
Done's Schemes: How Ukrainian Hryvnia Turns into Swiss Francs via Importers
Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Taras Vysotsky stated that alternative logistics corridors provide only 45% of the required volumes, threatening the loss of a significant portion of the harvest.

Lead State Prosecutor Taavi Pern confirmed that the activist was aware of the criminal liability for his actions, having contacted individuals who already had convictions for similar offences.

Investigators uncovered a scheme for the misappropriation of military property organised by the deputy commander of the unit. The process was later overseen by an SBU counter-intelligence officer assigned to the unit.

A representative of the ATB chain dispelled rumours about warehouse destruction, explaining that the buckwheat shortage is due to the cessation of supplies, while the disappearance of sugar is temporary.

European experts warn that restrictions on US diesel exports could become a trigger for a historic rise in prices on the continent.

Shevchenkivskyi District Court of Kyiv found two former prosecutors not guilty of demanding $150,000 to close a case.

Investigation revealed that custodian company Trustee Plus has legally ceased to exist, while customers face fund blocking under the pretext of audits.

A group of researchers has made a significant step in treating the consequences of stroke. According to data published in the scientific journal Nature Communications, the new drug DDL-920 allows for the complete restoration of neural connections, ensuring the return of motor functions and cognitive abilities.
To date, the study has been conducted on laboratory mice. The results showed that after the application of DDL-920, damaged neurons recover, and motor activity returns to normal. This effect offers hope for the possibility of full recovery for patients who have suffered a stroke, without residual impairments.
Scientists are already preparing to begin trials on humans. If the drug demonstrates similar efficacy and safety, it could become a revolutionary solution in stroke treatment.
Comments
No comments yet. Be the first!